The text has been copied to the clipboard
Back
Full-text
Journal article

The role of biosimilar manufacturers in improving access to insulin globally.

  • Perrin C Independent consultant, Paris, France.
  • Ewen M Health Action International, Amsterdam, Netherlands.
  • Beran D University of Geneva and Geneva University Hospitals, 1211 Geneva, Switzerland. Electronic address: david.beran@unige.ch.
  • 2017-06-21
Published in:
  • The lancet. Diabetes & endocrinology. - 2017
Biosimilar Pharmaceuticals
Drug Industry
Global Health
Health Services Accessibility
Humans
Hypoglycemic Agents
Insulin
Language
  • English
Open access status
bronze
Identifiers
Persistent URL
https://sonar.ch/global/documents/232799
Export to…
JSON data
Dublin Core
BibTeX
RIS (Zotero, …)
Statistics
Document views: 54 File downloads:
  • Full-text: 0